Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Deadliest Metastatic Cancer: Common Types and Their Prognosis Explained
Deadliest Metastatic Cancer: Common Types and Their Prognosis Explained 4

Almost 90% of cancer-related deaths result from metastatic disease, which happens when cancer spreads from its original site to other parts of the body. Understanding the risks and impacts of the  deadliest metastatic cancer  is important for both patients and caregivers.

Key Takeaways

  • Metastatic disease is responsible for nearly 90% of cancer deaths.
  • Understanding the signs and symptoms of metastatic cancer is key.
  • Treatments can slow disease progression and ease symptoms.
  • Stage 4 cancer needs a detailed treatment plan.
  • Early detection and treatment can lead to better outcomes.

Understanding Metastatic Cancer

Cancer spreading to different parts of the body is called metastasis. It’s a key sign of advanced cancer. This complex process involves several steps, leading to cancer cells spreading to distant organs.

What is Metastasis?

Metastasis is a multi-step process. Cancer cells break away from the primary tumor. They then invade surrounding tissues and enter the bloodstream or lymphatic system. “The ability of cancer cells to metastasize is a key factor in the poor prognosis of many cancer types.”

How Cancer Spreads Through the Body

Cancer cells spread through the body in several ways. They grow into nearby normal tissue. They move through the walls of nearby lymph nodes or blood vessels. They travel through the lymphatic system and bloodstream. They stop in small blood vessels at a distant location. This process is facilitated by various molecular mechanisms that enable cancer cells to survive and thrive in new environments.

Common Sites of Metastasis

Common sites for metastasis include the bone, liver, and lung. The specific sites of metastasis vary by cancer type. For example, breast cancer often goes to the bones. Lung cancer spreads to the brain, bones, and liver. Knowing these patterns is key for diagnosing and managing metastatic cancer.

As noted by cancer experts,

“The pattern of metastasis is not random; it is influenced by the type of cancer and the microenvironment of the target organ.” 

This knowledge is vital for creating effective treatment strategies.

Early Warning Signs of Metastatic Cancer

Deadliest Metastatic Cancer: Common Types and Their Prognosis Explained
Deadliest Metastatic Cancer: Common Types and Their Prognosis Explained 5

It’s important to know the early signs of metastatic cancer. This type of cancer, also known as stage 4, happens when cancer cells move to other parts of the body.

General Systemic Symptoms

General systemic symptoms affect the whole body. You might notice unexplained weight loss, extreme fatigue, or loss of appetite. These signs can mean cancer has spread to different parts of the body.

Site-Specific Symptoms

Site-specific symptoms happen when cancer goes to specific organs or areas. For example:

  • Cancer in the bone can cause pain and fractures.
  • Metastasis to the brain leads to headaches, seizures, or dizziness.
  • Cancer in the lung can make you feel short of breath.
Site of MetastasisCommon Symptoms
BonePain, Fractures
BrainHeadaches, Seizures, Dizziness
LungShortness of Breath

When to Seek Medical Attention

If you have persistent or severe symptoms, see a doctor right away. Early detection can greatly improve treatment results. If you notice any of these symptoms, talk to a healthcare professional quickly.

The Deadliest Metastatic Cancer Types

Some metastatic cancers are much deadlier than others. These cancers are aggressive and have low survival rates. Early detection and treatment are key.

Pancreatic Cancer Metastasis

Pancreatic cancer is very aggressive and has a poor prognosis when it spreads. Metastatic pancreatic cancer often goes to the liver, lungs, and peritoneum. This leads to a very low survival rate.

The five-year survival rate for this cancer is less than 3%. This shows we need better treatments.

Glioblastoma and Brain Cancer

Glioblastoma is the most aggressive brain cancer. It has a very poor prognosis. Even with treatment, glioblastoma patients usually live only 12 to 18 months after diagnosis.

The cancer grows fast and is hard to treat. This makes it a big challenge for doctors.

Small Cell Lung Cancer

Small cell lung cancer (SCLC) grows fast and spreads early. It’s hard to treat because it’s often widespread by the time it’s found. The five-year survival rate for SCLC is about 7% for those with extensive disease.

Mesothelioma and Its Prognosis

Mesothelioma is a rare and aggressive cancer linked to asbestos. The prognosis for mesothelioma patients is generally poor. They usually live 12 to 21 months after diagnosis.

The cancer is often diagnosed late. This, along with limited treatment options, makes survival rates low.

In conclusion, cancers like pancreatic cancer metastasis, glioblastoma, small cell lung cancer, and mesothelioma are very deadly. Understanding these cancers is key to finding better treatments and improving patient outcomes.

Metastatic Cancer Detection and Diagnosis

Deadliest Metastatic Cancer: Common Types and Their Prognosis Explained
Deadliest Metastatic Cancer: Common Types and Their Prognosis Explained 6

Finding metastatic cancer early is key. It takes several steps to do this. Knowing how far cancer has spread helps doctors plan the best treatment.

Imaging Technologies

Imaging is a big help in finding metastatic cancer. CT scans and MRI show where and how big tumors are. This info helps doctors see how far cancer has spread.

Biopsy Procedures

A biopsy takes a tissue sample from a tumor. It’s important to check for cancer cells and know the cancer type.

Blood Tests and Biomarkers

Blood tests look for biomarkers linked to cancer. These markers help doctors diagnose and track metastatic cancer.

Staging Metastatic Disease

Staging cancer is vital to understand its spread. It looks at tumor size, lymph nodes, and if cancer has spread.

Good diagnosis and staging are key for a treatment plan. They help meet the patient’s specific needs.

Factors Affecting Metastatic Cancer Prognosis

Metastatic cancer prognosis depends on many factors. Knowing these is key for patients and doctors to choose the right treatment.

Cancer Type and Primary Location

The type and where the cancer starts matter a lot. For example, pancreatic cancer and glioblastoma are tough to treat and have a bad outlook.

Common high mortality cancers include:

  • Pancreatic cancer
  • Glioblastoma
  • Small cell lung cancer
  • Mesothelioma

Extent of Metastatic Spread

How far the cancer has spread is very important. Cancer in many places or key organs is usually worse than cancer in just one or two spots.

Treatment Response Indicators

How a patient reacts to treatment is a big sign of how they’ll do. Those who get better from treatment usually have a better chance than those who don’t.

Factors influencing treatment response include:

  1. Genetic mutations within the cancer cells
  2. Overall health of the patient
  3. Specific treatments used

Patient Health and Age Factors

A patient’s health and age are also key. Older people or those with other health issues might not do as well with tough treatments.

Understanding these factors helps patients and doctors deal with metastatic cancer better. They can make better choices about care.

Treatment Approaches for Metastatic Cancer

Metastatic cancer treatment uses many therapies to fight cancer’s spread. The right treatment depends on the cancer type, where it is, and the patient’s health.

Systemic Therapies

Systemic therapies reach cancer cells all over the body. Chemotherapy is a key treatment for metastatic cancer. It kills fast-growing cancer cells. Hormone therapy is also used for cancers that respond to hormones.

Targeted Treatments

Targeted treatments aim at cancer cells’ unique traits, protecting normal cells. They are often more effective and have fewer side effects than chemotherapy. Targeted therapy drugs help treat many metastatic cancers.

Immunotherapy Options

Immunotherapy boosts your immune system to fight cancer. It makes your immune system attack cancer cells. Checkpoint inhibitors are a form of immunotherapy that help treat metastatic cancer.

Radiation Therapy for Metastases

Radiation therapy helps manage symptoms and slow tumor growth. It’s used for cancer in specific areas like bones or the brain. Stereotactic body radiation therapy (SBRT) gives high doses to small tumors.

Treatment TypeDescriptionApplication
Systemic TherapiesTreatments that reach cancer cells throughout the bodyChemotherapy, hormone therapy
Targeted TreatmentsTarget specific characteristics of cancer cellsTargeted therapy drugs
ImmunotherapyHelps the immune system fight cancerCheckpoint inhibitors
Radiation TherapyRelieves symptoms and controls tumor growthSBRT, external beam radiation

Understanding Survival Statistics and Outcomes

Survival rates for metastatic cancer patients change a lot based on the cancer type and when it’s found. These numbers help us know what to expect for patients.

Five-Year Survival Rates for Stage 4 Cancer

The five-year survival rate is a key way to judge how well cancer patients might do. For stage 4 cancer, this rate changes a lot depending on the cancer type. For example, stage 4 breast cancer survival rates are different from those for stage 4 pancreatic cancer.

Interpreting Cancer Mortality Statistics

Cancer mortality stats tell us how many deaths are due to cancer. Knowing these numbers helps us see if treatments are working and where we can do better.

Recent Advances Improving Outcomes

New treatments like targeted therapies and immunotherapies are showing promise. They might help some patients with metastatic cancer live longer.

Treatment-Resistant Cancer Challenges

But, cancer that doesn’t respond to treatment is a big problem. Scientists are working hard to find new ways to fight it.

By looking at survival stats and what affects them, patients and doctors can make better choices about treatment.

Living with Advanced Metastatic Disease

The journey with advanced metastatic disease is filled with challenges. Patients and their families face physical, emotional, and financial hurdles. They must navigate a complex healthcare system to manage symptoms, find the right care, and keep their quality of life high.

Managing Symptoms and Side Effects

Managing symptoms and side effects is key for those with advanced metastatic disease. It’s important to handle pain, fatigue, and other symptoms that affect daily life.

  • Pain relief strategies
  • Management of treatment side effects
  • Addressing psychological distress

Emotional and Psychological Support

Emotional and psychological support is essential for patients with advanced metastatic disease. They can get help from healthcare providers, support groups, and counseling services.

Financial and Insurance Considerations

The financial impact of advanced metastatic disease can be huge. It’s important to understand insurance, manage costs, and find financial help programs.

Support Resources and Organizations

Many organizations offer support and resources for patients with advanced metastatic disease. These include cancer advocacy groups, support hotlines, and online resources.

OrganizationResources OfferedContact Information
CancerCareCounseling, financial assistance, support groupswww.cancercare.org
American Cancer SocietyPatient support, education, advocacywww.cancer.org

Prevention and Early Detection Strategies

Early detection and prevention are key to fighting metastatic cancer. By understanding and using these strategies, people can lower their risk of advanced cancer.

Lifestyle Factors for Cancer Prevention

Keeping a healthy lifestyle is key to preventing cancer. Eat a balanced diet with lots of fruits, veggies, and whole grains. Stay active and avoid tobacco and too much alcohol. A healthy lifestyle can lower cancer risk.

Regular Screening Recommendations

Regular cancer screening is vital for early detection. Guidelines suggest screenings for breast, colon, and cervical cancers. Screening tests can find cancer before symptoms show, leading to better treatment outcomes.

Genetic Testing and Counseling

Genetic testing and counseling are important for those with a family history of cancer. They offer insights into cancer risk. This helps guide preventive steps and watchful waiting.

Monitoring for Cancer Recurrence

For cancer survivors, watching for recurrence is key. Regular check-ups and screenings help catch any return early. This makes treatment more effective.

Prevention StrategyDescriptionBenefit
Healthy DietRich in fruits, vegetables, and whole grainsReduces cancer risk
Regular ExerciseAt least 30 minutes of physical activity dailyLowers cancer risk and improves overall health
Genetic TestingIdentifies genetic mutations associated with cancerGuides preventive measures and surveillance

Conclusion

Metastatic cancer is a complex and challenging condition. It happens when cancer cells spread from the primary site to other parts of the body. We’ve looked at its symptoms, diagnosis, treatment options, and prognosis in this article.

A summary of metastatic cancer shows how important it is to understand the disease’s progression. Early detection is key. The prognosis varies based on the type and extent of metastasis, and the patient’s health.

Effective treatment for metastatic cancer involves a wide range of approaches. This includes systemic therapies, targeted treatments, immunotherapy, and radiation therapy. Ongoing research and support are vital to improve outcomes for patients.

By grasping the complexities of metastatic cancer, patients and healthcare providers can create personalized treatment plans. This can greatly improve the quality of life and survival rates for those with this disease.

FAQ

What is metastatic cancer?

Metastatic cancer spreads from its original place to other parts of the body. This happens when cancer cells break away and travel through the blood or lymphatic system. They then form new tumors in different areas.

What are the most common sites for metastasis?

Common places for metastasis include the bones, liver, lungs, and brain. Where cancer spreads often depends on the type of cancer.

What are the early warning signs of metastatic cancer?

Early signs include weight loss, fatigue, and pain. Symptoms also depend on where the cancer spreads. For example, bone pain or respiratory issues.

How is metastatic cancer diagnosed?

Doctors use CT scans, MRI, and PET scans to find metastatic cancer. They also do biopsies, blood tests, and check biomarkers to confirm the disease.

What are the deadliest types of metastatic cancer?

Pancreatic cancer, glioblastoma, small cell lung cancer, and mesothelioma are very aggressive. They have a poor prognosis.

How does the prognosis of metastatic cancer vary?

Prognosis depends on the cancer type, where it started, how far it has spread, and how well it responds to treatment. The patient’s health and age also play a role.

What treatment approaches are available for metastatic cancer?

Treatments include chemotherapy, targeted treatments, and immunotherapy. Radiation therapy helps manage symptoms and slow the disease’s growth.

What is the five-year survival rate for stage 4 cancer?

Survival rates vary by cancer type. Some aggressive cancers have less than a 5% five-year survival rate. Others may have a 30% or higher rate.

How can metastatic cancer be prevented or detected early?

Early prevention and detection involve a healthy lifestyle and regular screenings. Genetic testing and monitoring for recurrence are also important.

What support resources are available for patients with advanced metastatic disease?

Patients can find support through symptom management, emotional support, and financial help. Organizations offer guidance and advocacy.

What are the challenges posed by treatment-resistant cancer?

Treatment-resistant cancer is hard to treat. It has limited options, a poor prognosis, and needs more research for new therapies.

How do cancer mortality statistics inform our understanding of metastatic cancer?

Mortality statistics show survival rates for metastatic cancer. They help identify areas for improving treatment and care.

References

  • Mani, K., et al. (2024). Causes of death among people living with metastatic cancer. Nature Communications, 15, Article 45307.https://www.nature.com/articles/s41467-024-45307-x
  • DillekÃ¥s, H., Rogers, M., & Straume, O. (2019). Are 90% of deaths from cancer caused by metastases? Cancer Medicine, 8(12), 5574“5576.https://pmc.ncbi.nlm.nih.gov/articles/PMC6745820/
  • Li, Y., et al. (2025). Invasion and metastasis in cancer: molecular insights and therapeutic strategies. Signal Transduction and Targeted Therapy.https://www.nature.com/articles/s41392-025-02148-4
  • Globus, O., et al. (2023). Early death after a diagnosis of metastatic solid cancer: patterns and implications. PLOS ONE, 18(4), e0281561.https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0281561
i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 67 91